stars 1 stars 2 stars 3

Mercy BioAnalytics is on a mission to save lives and relieve suffering across the globe through the early detection of cancer. We have developed a novel liquid biopsy assay platform which interrogates tumor-derived extracellular vesicles, which are abundant in blood and carry information about their cell of origin, enabling detection of cancer even in at the earliest stages.

Mercy BioAnalytics, Inc. Questions

The Mercy BioAnalytics, Inc. annual revenue was $200000 in 2026.

Dawn Mattoon is the CEO of Mercy BioAnalytics, Inc..

56 people are employed at Mercy BioAnalytics, Inc..

Mercy BioAnalytics, Inc. is based in Waltham, Massachusetts.

The NAICS codes for Mercy BioAnalytics, Inc. are [54, 5417, 541713, 54171, 541].

The SIC codes for Mercy BioAnalytics, Inc. are [87, 873].

Top Mercy BioAnalytics, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users